IDR 18.0
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -32.95 Billion | -12.01 Billion | 14.68 Billion | 4.03 Billion | -37.25 Billion | -31.52 Billion |
Net Income | -11.74 Billion | -17.59 Billion | -11.6 Billion | -17.94 Billion | 28.76 Billion | 24 Billion |
Depreciation & Amortization | 4.72 Billion | 5.57 Billion | 5.49 Billion | 5.37 Billion | 4.47 Billion | 1.2 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -16.48 Billion | 12.01 Billion | 20.78 Billion | 16.61 Billion | -70.49 Billion | -54.32 Billion |
Investing Cash Flow | 27.85 Billion | 11.56 Billion | -1.79 Billion | -17.51 Billion | 6.81 Billion | -188.06 Billion |
Investments in PPE | -5.53 Billion | -466.26 Million | -116.88 Million | -11.77 Billion | -50.54 Billion | -72.61 Billion |
Acquisitions | - | - | - | 37.02 Billion | 1.34 Billion | - |
Investment purchases | - | - | -1.67 Billion | -37.02 Billion | -1.34 Billion | -115.44 Billion |
Sales/Maturities of investments | 33.39 Billion | 12.03 Billion | - | 31.28 Billion | 58.71 Billion | - |
Other Investing Activities | 27.9 Billion | 12.03 Billion | -1.67 Billion | -37.02 Billion | -1.34 Billion | -25.44 Billion |
Financing Cash Flow | 14.02 Billion | -5.64 Billion | -12.97 Billion | -436.82 Million | 12.44 Billion | 257 Billion |
Debt repayment | -14.02 Billion | -74.94 Billion | -8.21 Billion | -1.73 Billion | -10.94 Billion | -39.69 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | 296.69 Billion |
Other Financing Activities | -19.94 Billion | 69.29 Billion | -4.76 Billion | 1.29 Billion | 23.39 Billion | 310.86 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 8.3 Billion | 26.8 Billion | 26.89 Billion | 40.8 Billion | 39.69 Billion | 2.28 Billion |
Cash at end of period | 17.23 Billion | 8.3 Billion | 26.8 Billion | 26.89 Billion | 40.8 Billion | 39.69 Billion |
Capital Expenditure | -5.53 Billion | -466.26 Million | -116.88 Million | -11.77 Billion | -50.54 Billion | -72.61 Billion |
Effect of forex changes on cash | - | -12.39 Billion | - | - | 19.1 Billion | - |
Net cash flow / Change in cash | 8.92 Billion | -18.49 Billion | -93.88 Million | -13.91 Billion | 1.11 Billion | 37.41 Billion |
Free Cash Flow | -38.49 Billion | -12.48 Billion | 14.56 Billion | -7.74 Billion | -87.8 Billion | -104.14 Billion |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 437.47 Million | 2.53 Billion | -2.27 Billion | -11.74 Billion | -7.32 Billion | -2.62 Billion |
Depreciation & Amortization | 1.02 Billion | 1.02 Billion | 1.02 Billion | 4.72 Billion | 540.96 Million | 1.39 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | 1.37 Billion | -11.89 Billion | -7.99 Billion | -16.48 Billion | -11.66 Billion | -1.35 Billion |
Investing Cash Flow | -3.3 Billion | -154.14 Million | 1.24 Billion | 27.85 Billion | 14.05 Billion | -1.01 Billion |
Investments in PPE | -3.5 Billion | 2.00 | - | -5.53 Billion | -5.51 Billion | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | 198.09 Million | -154.14 Million | 1.24 Billion | 33.39 Billion | 19.56 Billion | -1.01 Billion |
Other Investing Activities | - | -154.14 Million | 1.24 Billion | 27.9 Billion | 14.08 Billion | -1.01 Billion |
Financing Cash Flow | -1.01 Billion | -532.57 Million | 12.36 Billion | 14.02 Billion | -21.09 Billion | 40.79 Billion |
Debt repayment | -1.01 Billion | -532.57 Million | -12.36 Billion | -14.02 Billion | -21.09 Billion | -765.56 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -532.57 Million | -497.95 Million | -19.94 Billion | -18.84 Billion | 41.55 Billion |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 8.48 Billion | 19.55 Billion | 17.23 Billion | 8.3 Billion | 43.8 Billion | 6.6 Billion |
Cash at end of period | 6.99 Billion | 8.48 Billion | 19.55 Billion | 17.23 Billion | 17.23 Billion | 43.8 Billion |
Capital Expenditure | -3.5 Billion | 2.00 | - | -5.53 Billion | -5.51 Billion | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.49 Billion | -11.07 Billion | 2.32 Billion | 8.92 Billion | -26.57 Billion | 37.19 Billion |
Free Cash Flow | -673.75 Million | -10.38 Billion | -11.29 Billion | -38.49 Billion | -25.04 Billion | -2.58 Billion |
ARV
TNON
FGP
MEDINOV
7359
PGSUS